PI Industries is engaged in the business of – Agri inputs, fine chemicals, and (CRAMS) contract research and manufacturing services. and it is a leading player in the agrochemicals space, having a solid presence in domestic and export markets.

Shares of PI Industries Ltd. were trading at ₹ 3455.10 gaining 1.06 % on Thursday’s trading session from the previous close price of ₹3415. The company has a market cap of ₹ 52,420 crore.

Having a quick walkthrough of the financials, their operating revenues decreased from  ₹ 1,613  crores in Q3 to ₹1,565 crores in Q4. Similarly, having a YoY comparison of the metrics, the revenues significantly increased by 22.5 percent from ₹ 5,299 crores during FY 21-22 to ₹ 6,492 crores in FY 22-23.


The net profits of the company, during the previous quarter, declined from ₹351 crore in Q3 to ₹279 crore in Q4. For YOY comparison, PAT numbers have significantly increased by 45 percent, from ₹ 840 crores during FY 21-22 to  ₹ 1,222 crores in FY 22-23.

Having a positive outlook for the company, here are the targets given by analysts:

Axis Securities

The brokerage has given a buy call on PI Industries Ltd. with a target price of ₹ 4000. The brokerage recommended that a stop-loss be kept at ₹2850. This is an upside of 16%.

Zerodha banner mob

Sharekhan brokerage 

The brokerage has recommended a buy call on PI Industries Ltd. with a target price of ₹ 4200 indicating an upside of 21%.

The rationale behind giving such a recommendation is 

  • To integrate its R&D capabilities, PI Industries completed the twin acquisition through PI Health Sciences Ltd., a 100% subsidiary of PI.
  • In Hyderabad, a new pharmaceutical research centre is being built. The management estimates a topline of 550-600 Cr with EBITDA margins of 15-18%.
  • Working capital improved to 75 days in FY23 vs. 94 days YoY.
  • 4 new molecules were launched in FY23, & plans are to launch 5 new molecules in FY24, with 40+ products in development stages.

According to the latest data pertaining to the shareholding pattern, promoters of the company hold a 46.09 percent stake, and foreign institutional investors (FIIs) hold an 18.59 percent stake in the company for FY 22-23.

Written by Omkar C


The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

To stay updated with the Latest Stock Market news, download our app here!

For editorial purposes, contact news@tradebrains.in

Start Your Stock Market Journey Today!

Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!